Top Markets
Coin of the day
Roquefort Therapeutics plc Roquefort Therapeutics plc

Roquefort Therapeutics plc

ROQ
Rangering i aksjer #37956
Roquefort Therapeutics plc functions as a biotechnology firm, focusing its... Roquefort Therapeutics plc functions as a biotechnology firm, focusing its efforts on the discovery and development of innovative pharmaceutical treatments. The company's primary research objective is to develop therapies that target Midkine, a circulating growth factor protein and pro-inflammatory mediator, for applications in cancer treatment. Established in 2020, Roquefort Therapeutics plc has its main operations based in London, United Kingdom.
Aksjekurs
$0.10205262
Sist synkronisert: 2026-04-23
Markedsverdi
$1.32M
Endring (1 dag)
5.19%
Endring (1 år)
-54.38%
Land
GB
Handel Roquefort Therapeutics plc (ROQ)

Kategori

Historikk for aksjesplitt for Roquefort Therapeutics plc (ROQ)
Aksjen Roquefort Therapeutics plc (symbol: ROQ) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 15, 2026.
Én ROQ-aksje kjøpt før Aug 15, 2026 tilsvarer i dag 0 ROQ-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE